eli lilly clinical trials tirzepatide Lilly's Shows Promise in Treating Fatty Liver Disease FDA approval for Zepbound (tirzepatide)

Tirzepatide injection timing flexibility lets you choose morning or evening doses based on your schedule and tolerance

Together, they create a synergistic blend to support bowel regularity and overall gut health

GLP-1s arent just a get skinny quick trend

Heres what federal annuitants need to know This summer, the Centers for Medicare & Medicaid Services (CMS) is launching the Medicare GLP-1 Bridge program, which extends coverage of GLP-1 weight-loss medications to eligible Medicare Part D beneficiaries, regardless of whether they have an underlying medical condition

Notably, delayed gastric emptying, a dose-dependent side effect, raises concerns of pulmonary aspiration during general anesthesia